Amigo Digital Residency
Reliable clinical agents, trained like doctors on millions of simulated patient interactions
Company profile
Company profile
Amigo AI is a healthcare AI infrastructure company that provides a unified platform for building, training, and deploying clinical agents across multiple care specialties. The company's core innovation is its 'Digital Residency' approach, which trains AI agents on millions of simulated patient interactions before they interact with real patients, mirroring the rigorous training process used for human clinicians. The platform serves healthcare organizations across primary care, orthopedics, women's health, behavioral health, cancer care, and digital health, enabling them to expand clinical capacity while maintaining safety and reliability standards. Amigo's platform handles the complete lifecycle from defining workflows and clinical reasoning, through training on virtual patient populations, to deployment with EHR integration, and continuous monitoring and improvement. The company emphasizes a consultative partnership model with deployment timelines as short as six weeks. With over 3 million patient encounters processed, the platform claims to increase clinical capacity by 10x while maintaining a 98% rate of patient interactions that don't require human escalation. Amigo maintains full HIPAA, SOC 2, and GDPR compliance and integrates natively with all major EHR systems. The company is backed by venture capital and serves healthcare leaders worldwide, positioning itself as the foundational AI operating system for healthcare rather than a collection of point solutions.
Company description Amigo AI official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Recorded integration context: All major EHRs (Epic, Cerner mentioned as supported), Clinical systems, Patient portals, SMS platforms, Voice systems.
Company milestones
Platform approach article published May 2026. Chief Medical Officer Dr. Jay Shah joined from Stanford Health Care. Processing 3M+ patient encounters worldwide.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Reliable clinical agents, trained like doctors on millions of simulated patient interactions
The trusted platform for building, training, and deploying clinical agents
Custom clinical agents for your unique patients and workflows
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Diabetes, obesity & metabolism · Aug 10, 2026
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Overall platform impact
Customer ROI
Platform scale
Agent autonomy
Safety validation
Agent responsiveness
Time to value
Building clinical agents with safety guardrails for digital health workflows
Unique vendor capability with rapid build times and safety requirements
Clinical agent deployment across multiple organizations
3M+ patient encounters worldwide, 34x return on investment, 98% of patient interactions do not require human escalation, 100% pass rate on clinical safety metrics, 0 min response time
Clinical capacity expansion using AI agents trained to Stanford's clinical standards
10x increase in clinical capacity
Custom clinical agent development and deployment
Superior engagement and implementation experience compared to other vendors
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Amigo AI's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing generative AI platforms, large language models (LLMs), foundation models, or broad AI infrastructure specifically designed for healthcare applications. These companies serve multiple clinical use cases across the health system rather than focusing on a single clinical application or disease area.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.